| CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV LH Chaisson, V Saraceni, S Cohn, D Seabrook, SC Cavalcante, ... Aids 34 (1), 139-147, 2020 | | 2020 |
| Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV EA Kendall, B Durovni, NA Martinson, S Cavalacante, K Masonoke, ... Aids 34 (1), 63-71, 2020 | | 2020 |
| Detection and molecular characterization of urinary tract HIV-1 populations ML Mzingwane, G Hunt, R Lassauniere, M Kalimashe, A Bongwe, ... Annals of clinical microbiology and antimicrobials 18 (1), 1-7, 2019 | | 2019 |
| Isoniazid Preventive Therapy and Pregnancy Outcomes In HIV-Infected Women in the Tshepiso Cohort N Salazar-Austin, S Cohn, S Lala, Z Waja, KE Dooley, CJ Hoffmann, ... Clinical Infectious Diseases, 2019 | | 2019 |
| CD4 count stratification to guide tuberculosis preventive therapy for people living with HIV. LH Chaisson, V Saraceni, S Cohn, D Seabrook, S Cavalcante, ... AIDS (London, England), 2019 | 1 | 2019 |
| One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply RE Chaisson, R Ramchandani, S Swindells The New England journal of medicine 381 (11), e23, 2019 | | 2019 |
| High prevalence of rifampin-resistant tuberculosis in mountainous districts of India K Dorjee, TD Sadutshang, RS Rana, S Topgyal, D Phunkyi, T Choetso, ... Indian Journal of Tuberculosis, 2019 | | 2019 |
| Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials S Miyahara, R Ramchandani, S Kim, SR Evans, A Gupta, S Swindells, ... Clinical Infectious Diseases, 2019 | | 2019 |
| Applying Risk-Benefit Analysis to Outcomes in TB Clinical Trials. S Miyahara, R Ramchandani, S Kim, SR Evans, A Gupta, S Swindells, ... Clinical infectious diseases: an official publication of the Infectious …, 2019 | | 2019 |
| Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans GW Koor, M Paximadis, ACP Picton, F Karatas, SA Loubser, W He, ... Clinical Immunology 205, 16-24, 2019 | | 2019 |
| Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration N Salazar-Austin, DW Dowdy, RE Chaisson, JE Golub American Journal of Epidemiology, 2019 | | 2019 |
| Exposure to Latent Tuberculosis Treatment during Pregnancy RN Moro, NA Scott, A Vernon, NK Tepper, SV Goldberg, K Schwartzman, ... | | 2019 |
| Bone marrow stromal antigen-2 (bst-2) gene variants associate with HIV-1 control in black South African individuals BDC Dias, M Paximadis, Z Waja, N Martinson, RE Chaisson, O Ebrahim, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 22, 41-42, 2019 | | 2019 |
| 70 years of TB Prevention: Efficacy, Effectiveness, Toxicity, Durability and Duration. N Salazar-Austin, DW Dowdy, RE Chaisson, JE Golub American journal of epidemiology, 2019 | | 2019 |
| Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis V Saini, NC Ammerman, YS Chang, R Tasneen, RE Chaisson, S Jain, ... Antimicrobial agents and chemotherapy 63 (6), e00388-19, 2019 | 1 | 2019 |
| Improving TPT Uptake: A Cluster-Randomized Trial of Symptom-Based Versus Tuberculin Skin Test-Based Screening of Household Tuberculosis Contacts Less than 5 Years of Age N Salazar-Austin, S Cohn, GL Barnes, M Tladi, K Motlhaoleng, ... Clinical Infectious Diseases, 2019 | 1 | 2019 |
| Addressing critical needs in the fight to end tuberculosis with innovative tools and strategies M Hatherill, RE Chaisson, CM Denkinger PLoS medicine 16 (4), e1002795, 2019 | | 2019 |
| Building a tuberculosis-free world: The Lancet Commission on tuberculosis MJA Reid, N Arinaminpathy, A Bloom, BR Bloom, C Boehme, R Chaisson, ... The Lancet 393 (10178), 1331-1384, 2019 | 43 | 2019 |
| One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis S Swindells, R Ramchandani, A Gupta, CA Benson, J Leon-Cruz, ... New England Journal of Medicine 380 (11), 1001-1011, 2019 | 38 | 2019 |
| Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection S Keshavjee, F Amanullah, A Cattamanchi, R Chaisson, KM Dobos, ... American journal of respiratory and critical care medicine 199 (5), 564-571, 2019 | 1 | 2019 |
Jonathan GolubAssociate Professor, Johns Hopkins UniversityVerified email at jhmi.edu
